Trialbee Patient Recruitment Services Selected to Promote Patient Diversity for Leading COVID-19 Vaccine Trials

Trialbee is pleased to announce that we are providing patient recruitment services to promote patient diversity for vaccine trials investigating the safety and efficacy of leading vaccine candidates against COVID-19 and funded by BARDA, part of the HHS Office of the Assistant Secretary for Preparedness and Response.

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials

Trialbee is pleased to announce our partnership with Clinerion to accelerate time to market by shortening patient recruitment and enrollment timelines and reduce costs associated with patient recruitment and loss-to-follow-up.

Clinical Trials Arena: Trialbee and Datavant to partner for clinical trial recruitment

Learn more about Trialbee’s partnership with Datavant to power clinical trial recruitment in this article from Clinical Trials Arena. 

FinanzNachrichten.de: Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Learn more about Trialbee’s partnership with Datavant to power clinical trial recruitment in this article from FinanzNachrichten.de. 

TMCnet: Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Learn more about Trialbee’s partnership with Datavant to power clinical trial recruitment in this article from TMCnet. 

Pharmaceutical Daily: Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Learn more about Trialbee’s partnership with Datavant to power clinical trial recruitment in this article from Pharmaceutical Daily. 

Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Trialbee today announced a partnership with Datavant, the leader in privacy-protecting data connectivity, to more effectively and efficiently recruit clinical trial participants.

Trialbee Secures €11 million in Funding to Scale Digital Patient Trial Recruitment and Engagement Solutions

Trialbee announces the closure of an €11 million investment round to onboard strategic investor MTIP, the European specialist investor in Healthtech scale-up companies. Existing investors Industrifonden and Briban Invest also participated in the round.

Trialbee Celebrates Triple Digit Growth Year over Year

Company’s positive trajectory with revenue, partnerships, and customers to continue with a strong outlook in 2020

Trialbee announces strong sales results and a 10 yearlong patient engagement and retention assignment

MALMÖ, SWEDEN and RESEARCH TRIANGLE PARK, NC — September 3, 2019 —

Trialbee announces strong sales results in H1 2019 and the launch of a 10 yearlong assignment for its engagement and retention technology with one of the largest global pharmaceutical companies.

Trialbee, a leading technology company in the development of innovative software to reduce clinical trial recruitment timelines and increase the patient engagement experience, announces the appointment of Richard Thomas as its new member to its Board of Directors.

Trialbee delivered strong YoY sales result for its patient matching and engagement technology and exceeded its H1 2019 sales target by 26%. The sales uptake in H1 2019 is predominately driven by growth within the pharmaceutical customer segment. H1 has also demonstrated an increased interest among some of the leading global Contract Research Organizations, a trend the company believes will continue to develop. Sales in H1 is also indicating that customers are requesting to onboard Trialbee’s technology earlier in the drug development process, which is in line with Trialbee’s sales strategy. The technology platform is gaining more momentum as an embedded solution from clinical trial planning through the patient retention phase.

“We are pleased to note that our solutions are delivering demonstrable recruitment and retention efficiencies for our customers, which has advanced Trialbee to become an embedded healthcare partner with major clients, a key strategic driver for continued double digit growth.” Robert Molander, Chief Commercial Officer at Trialbee, said.

In addition to the strong sales result in H1, Trialbee was also successful in landing its longest engagement and retention assignment with one of the largest pharmaceutical companies. Trialbee’s engagement technology will follow more than 3,000 subjects over a 10-year period to support timely and accurate monitoring of questionnaire completeness. The assignment demonstrates the potential of the technology and future applications, but also the high value it delivers to patients and sponsors in securing reliable long-term study outcomes.

About Trialbee:

Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option. Founded in 2010, Trialbee has continuously innovated patient-centric technology solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data. For more information, visit trialbee.com and contact us at [email protected]

 

Press Contact:
Robert Grimm

+46(0)76-525 82 11
[email protected]

Investor Contact:
Daniel Spasic

Executive Chairman Trialbee
[email protected]

Cookie Preferences

Cloudflare

The Cloudflare cookie is used to identify individual clients behind a shared IP address and apply security settings on a per-client basis.

PHPSESSID,wp-settings-time-1

Google Analytics

Used by Google AdWords to re-engage visitors that are likely to enrol based on the visitor's online behaviour across websites.

_ga,_gid,_gat_UA,_utmc,UULE,CONSENT,1P_JAR,DV

Trialbeehealth

Wordpress built-in cookies to keep user settings after page transitions.

PHPSESSID,wp-settings-time-1

Functional cookies

Allow our websites to remember your user name, language preference, or geographic region. This information is used to provide a personalized experience and to make the website easier to use. If you don’t allow these cookies, then some or all features may not function

variable1

Performance cookies

Collect information about your use of our website, e.g. page visits or error messages. This information is aggregated and anonymized and used to improve our website. If you don’t allow these cookies, we won’t know when you have visited our website and won’t be able to monitor its performance

variable2

Advertising cookies

Allow us to display advertising we think is relevant to you. We build profiles based on your browsing history, which we share with our advertising partners to show you relevant advertisements on other sites. If you don’t allow these cookies you will still receive advertising, but it will be less relevant

variable3

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?